Drinking coffee halves the risk of liver cancer!

« Go Back

Article by Micheal Carter.

Coffee consumption reduces the risk of liver cancer by approximately 50%, the results of a meta-analysis published in the online journal BMC Gastroenterology show. A total of 16 studies published before May 2012 were included in the analysis. Closer examination of the results suggested that the magnitude of the protective effective of drinking coffee was higher among men than women and also differed between patients of Asian and European origin. However, the authors do not believe their results are definitive and call for further research.

Liver cancer is an increasingly important cause of illness and death in both men and women. Infection with hepatitis B or C and excessive alcohol consumption are known risk factors for the malignancy. Factors protective against the development of liver cancer are uncertain, and the impact of coffee consumption is especially controversial.

A team of Chinese investigators therefore performed a meta-analysis of case-controlled and cohort studies examining the impact of coffee consumption and the risk of liver cancer.

Nine case-controlled and seven cohort studies met the investigators’ inclusion criteria. A total of eleven studies were conducted in Asia (nine in Japan) and five in Europe. All the studies provided data on the risk of liver cancer according to coffee consumption. However, there was little heterogeneity between the design of the studies. In particular, the level of coffee consumption against which the risk of liver cancer was assessed varied considerably, from as little as one cup each day to as many as eight or more daily cups.

Overall, the investigators found that a high coffee intake reduced the risk of liver cancer by 50% (OR = 0.50; 95% CI, 0.42-0.59). The protective effect of coffee consumption was similar in the case control studies (OR = 0.50; 95% CI, 0.40-0.63) and the cohort studies (OR = 0.48; 95% CI, 0.398-0.62).

Adjusting the results to take account of liver disease status provided similar results (OR = 0.54; 95% CI, 0.46-0.66).

“The results of the current meta-analysis…suggest that there is an inverse association between coffee consumption and liver cancer among different groups according to consumption level,” comment the investigators. “There were significant reductions of 50% in the risk of liver cancer with the highest consumption of coffee compared with non/almost never consumption.”

Stratifying the results by region suggested that the degree of protection provided by coffee consumption was higher in Asia (OR = 0.45; 95% CI, 0.36-0.56) than Europe (OR = 0.57; 95% CI, 0.44-0.75).

“The different results may be explained by racial differences,” suggest the authors. “Differences in coffee drinking habits may be a partial explanation for the discrepancy.”

Analysis according to sex showed that drinking coffee reduced the risk of liver cancer by 62% in men (OR = 0.38; 95% CI, 0.25-0.56) and by 40% in women (OR = 0.60; 95% CI, 0.33-1.10).

The authors note that caffeine has antioxidant properties, possibly explaining the protective effect of coffee consumption. However, the meta-analysis was unable to show the level of coffee consumption needed to provide protection against liver cancer.

“The results of this meta-analysis suggested that coffee consumption may be associated with a reduced risk of liver cancer,” the authors conclude. “However, because of potential confounding, this finding should be treated with caution. Further better-controlled studies are needed to confirm this finding.”


Sang L et al. Consumption of coffee associated with reduced risk of liver cancer: a meta-analysis. BMC Gastroenterology, doi: 10.1186/1471-1230X-13-34, 2013.

Home | Services | News | Events | Semi-Permanent Stands | Office Coffee Solutions | Contact
© Copyright Caffeine Hotspot. All Rights Reserved. Website hosted by LIT Creations. You are visitor number: 125655